RT Journal Article
SR Electronic
T1 Show us the Data: Global COVID-19 Wastewater Monitoring Efforts, Equity, and Gaps
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.03.14.21253564
DO 10.1101/2021.03.14.21253564
A1 Naughton, Colleen C.
A1 Roman, Fernando A.
A1 Alvarado, Ana Grace F.
A1 Tariqi, Arianna Q.
A1 Deeming, Matthew A.
A1 Bibby, Kyle
A1 Bivins, Aaron
A1 Rose, Joan B.
A1 Medema, Gertjan
A1 Ahmed, Warish
A1 Katsivelis, Panagis
A1 Allan, Vajra
A1 Sinclair, Ryan
A1 Zhang, Yihan
A1 Kinyua, Maureen N.
YR 2021
UL http://medrxiv.org/content/early/2021/11/28/2021.03.14.21253564.abstract
AB A year since the declaration of the global coronavirus disease 2019 (COVID-19) pandemic there were over 110 million cases and 2.5 million deaths. Learning from methods to track community spread of other viruses such as poliovirus, environmental virologists and those in the wastewater based epidemiology (WBE) field quickly adapted their existing methods to detect SARS-CoV-2 RNA in wastewater. Unlike COVID-19 case and mortality data, there was not a global dashboard to track wastewater monitoring of SARS-CoV-2 RNA worldwide. This study provides a one year review of the “COVIDPoops19” global dashboard of universities, sites, and countries monitoring SARS-CoV-2 RNA in wastewater. Methods to assemble the dashboard combined standard literature review, direct submissions, and daily, social media keyword searches. Over 200 universities, 1,000 sites, and 55 countries with 59 dashboards monitor wastewater for SARS-CoV-2 RNA. However, monitoring is primarily in high-income countries (65%) with less access to this valuable tool in low and middle income countries (35%). Data are not widely shared publicly or accessible to researchers to further inform public health actions, perform meta-analysis, better coordinate, and determine equitable distribution of monitoring sites. For WBE to be used to its full potential during COVID-19 and beyond, show us the data.Competing Interest StatementThe authors have declared no competing interest.Funding StatementFunding sources include: a Center for Information Technology Research in the Interest of Society (CITRIS) COVID-19 emergency seed grant, Bill and Melinda Gates Foundation, and National Science Foundation (NSF) #2027752 and #2038087. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the National Science Foundation or other funding agencies.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:UC Merced IRBI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data is available publicly through ArcGIS online. A link to our public dashboard is here: https://arcg.is/1aummW